Palatin Technologies

0 followers

‌

Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system.

Industries

Pharmaceutical, Biotechnology

Headquarters

Cranbury, United States

Employees

51-200

Links

Org chart

Carl Spana

CEO, President & Director

Carl Spana

Collapse

Stephen T. Wills

COO, CFO, Treasurer & Secretary

Stephen A. Slusher

Chief Legal Officer

Samrat Sisodia

VP, Regulatory Affairs & Quality Assurance

Michael B. Raizman

Chief Medical Officer

John Dodd

SVP, Preclinical Development

Paul Kayne

VP, Biological Sciences

J. Don Wang

VP, Product Development

Don Wang

Vice President, Prod Dev (CMC)

Johna Lucas

Chief Medical Officer

John Prendergast

Co-Founder and Chairman of the Board

Teams

Leadership Team

11 members

Research and Development

6 members

Clinical Operations and Regulatory Affairs

4 members

Similar companies

Kura Oncology

18 followers

REVOLUTION Medicines

5 followers

AbbVie

178 followers

Relay Therapeutics

1 follower

Volastra

1 follower

Novavax

8 followers

Recursion Pharmaceuticals

7 followers

Amgen

214 followers

Eikon Therapeutics

1 follower

Scribe Therapeutics

1 follower

Bristol-Myers Squibb

187 followers

Explore companies